StockWatch
·
GRASIM INDUSTRIES LTD. · Q2 FY-2027 · PREVIEW

Growth momentum on track—watch new capacity ramp and margin hold

Grasim enters Q2 off a record Q1 (revenue +21%, EBITDA +26% YoY), with three new business engines scaling (Epichlorohydrin plant live, Birla Opus paints, B2B e-commerce breakeven in sight) and promoter confidence crystallizing. Street remains bullish on 16%+ EBITDA upside and full-year guidance, but margin resilience in a mixed cost environment will be key.

Q2 FY27 resultsGRASIMGRASIM INDUSTRIES LTD.08 Nov 2026 · 3 min read

What to Expect

Grasim delivered record Q1 FY2027 revenue of ₹48,716 Cr (+21% YoY) and EBITDA of ₹8,077 Cr (+26% YoY, 16% margin), marking the 24th consecutive quarter of revenue growth. The company is guiding for Paints (Birla Opus) >50% revenue growth and B2B e-commerce (Birla Pivot) EBITDA breakeven by end-FY2027. For Q2, expect momentum to largely persist—the question is margin. With new production capacity live (Epichlorohydrin plant started Oct 21), the quarter should show volume growth across Cement, Chemicals, and Fibres. EBITDA margin resilience will hinge on input costs (pulp, fibre feedstock, energy) and realization in international markets.

Revenue expectation

~₹48–50 Cr

Q1 set ₹48.7 Cr at +21% YoY; Q2 typically softer than Q1 in cement. Assume 18–22% YoY growth.

EBITDA margin

~16%

Q1 held 16% on higher volumes and product mix. New Epichlorohydrin capacity ramps; margin resilience vs raw material inflation key.

Adjusted PAT growth

High-teens to mid-20s%

Q1 Adj. PAT +49% YoY on operating leverage and one-offs. Normalize to core run-rate ~20% growth.

Cash and capital

Debt/EBITDA ~1.45x

Target maintained below 2.0x through FY27. Continued CP repayments (₹3,050 Cr repaid Sep–Nov) signal comfort.

A strong Q2 print would show revenue at or above ₹49 Cr (+19% YoY+), EBITDA margin stable-to-expanding, and early evidence of Epichlorohydrin plant contributing to Chemicals EBITDA. Weak print would be revenue below ₹48 Cr, EBITDA margin compression below 15%, or guidance qualification on FY27 targets. However, given Q1's record and management's track record, consensus expects the company to deliver on-plan.

On Track?

Yes. Q1 revenue +21% YoY and EBITDA +26% YoY mark the strongest quarter on record. The company is executing its three-part growth plan: (1) Core legacy Cement + Chemicals + Fibres remain stable-to-growing (Cement +16% vol in Q1, Chemicals EBITDA +16% YoY); (2) New capacity is live or imminent (Epichlorohydrin 50,000 TPA started production Oct 21; Solenergi acquisition CCI-cleared Oct 30, adding renewable energy capacity); (3) Growth engines scale (Paints targeting >50% revenue growth YoY with breakeven EBITDA by FY27; B2B e-commerce Birla Pivot breakeven expected by year-end). Net debt/EBITDA at 1.45x vs 1.62x in Q1 FY26 shows balance-sheet discipline. Management has not issued full-year P&L guidance (revenue/EBITDA), so all signals point to confidence in executing on the trajectory.

What the Street Says

Since Last Quarter

Operational progress: Grasim commissioned its Epichlorohydrin (ECH) plant in Vilayat, Gujarat on Oct 21, 2026. Capacity: 50,000 TPA. This is a new specialty chemical product for the company, supporting higher-margin chemical EBITDA. M&A: Subsidiary Aditya Birla Renewables (ABReN) received CCI approval on Oct 30 for the 100% acquisition of Solenergi Power—adding utility-scale renewable energy capacity to the portfolio. Partnerships: Grasim's Advanced Materials Division signed an MoU with Suzlon Energy on Oct 4 to develop recyclable wind turbine blades, broadening the renewables value chain. Debt management: Aggressive CP repayment—₹750 Cr repaid on Sep 24, Sep 18, Oct 26, and Nov 4; ₹800 Cr on Sep 11, Sep 18. Total ~₹3,050 Cr in Q2–Q3. Ownership: Birla Group Holdings (Kumar Mangalam Birla and persons acting in concert) acquired a 4.60% stake in Sep 2026—confidence signal. Regulatory: Bombay HC on Oct 25 quashed a ₹329 Cr tax reassessment notice, a legal win. ESG: CRISIL upgraded ESG rating to 'Crisil ESG 65' (Strong) in Aug 2026, up from 61; NSE rating also improved to 'Aspiring' (65 points). None of these are headwinds; the narrative is progress on new capacity, capital return confidence, and strategic partnerships.

The Setup

GRASIM enters Q2 as a compounder on its best trajectory in years: record Q1, three new business engines scaling, promoter conviction reflected in 4.6% stake buy, and Street consensus unanimously bullish. The stock trades near 52-week lows-to-ATH (-5.4% from ₹3,411), leaving room for re-rating. Q2 will test whether the company can sustain EBITDA margin and convert new capacity into earnings accretion. The real watch is not top-line (that's likely to deliver; Q1 was +21%), but rather margin hold and early evidence that Epichlorohydrin and renewables are scaling as promised.

Key Watch Items on Result Day
  • 1 · EBITDA margin hold/expand vs input inflation

    Pulp and fibre feedstock costs remain volatile globally. Can Grasim hold 16% EBITDA margin or improve it despite Q2 seasonality? If margin compresses below 15%, it signals raw material headwinds are not being fully offset by pricing/mix.

  • 2 · Epichlorohydrin contribution and ramp guidance

    Plant started Oct 21. Q2 will show early production/sales. Look for management commentary on run-rate capacity utilization by year-end and EBITDA impact in H2 FY27.

  • 3 · Paints (Birla Opus) and B2B e-commerce (Birla Pivot) trajectory

    Guidance is >50% revenue growth for Paints and breakeven EBITDA by FY27. Q2 will show whether growth is on-plan and profitability path is credible.

  • 4 · Cement volume and pricing dynamics

    Cement represented 35%+ of EBITDA in prior years. Q2 typically sees seasonal softness. Monitor volume growth and pricing power given competition and monsoon-driven construction lag.

  • 5 · Solenergi integration timeline and ABReN's runway to profitability

    M&A closed ~Oct 30. Look for management's integration plan and updated capital requirements. Any update on when renewables EBITDA turns accretive?

Informational and educational content only. Not investment advice.